Oncolytics Biotech Inc.

NASDAQ: ONCY · Real-Time Price · USD
0.33
-0.01 (-2.91%)
At close: Jun 05, 2025, 3:59 PM
0.33
0.09%
After-hours: Jun 05, 2025, 06:33 PM EDT
-2.91%
Bid 0.33
Market Cap 29.53M
Revenue (ttm) n/a
Net Income (ttm) -31.71M
EPS (ttm) -0.29
PE Ratio (ttm) -1.15
Forward PE -0.86
Analyst Buy
Ask 0.36
Volume 648,608
Avg. Volume (20D) 482,780
Open 0.34
Previous Close 0.34
Day's Range 0.33 - 0.34
52-Week Range 0.33 - 1.53
Beta 1.19

About ONCY

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ONCY
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ONCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
+24.56%
Oncolytics Biotech shares are trading higher after... Unlock content with Pro Subscription
8 months ago
+18.22%
Oncolytics Biotech shares are trading higher after the company announced key progress and upcoming studies for breast and pancreatic cancer treatments while also preparing for an accelerated FDA approval path.